NovoCure Limited (NVCR) NASDAQ
15.82
-0.74(-4.47%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.44B |
| Enterprise Value | 1.63B |
| P/E Ratio | -10.44 |
| PEG Ratio | 0.79 |
| Price/Sales Ratio | 2.72 |
| Price/Book Ratio | 5.46 |
| Enterprise/Revenue | 2.92 |
| Enterprise/EBITDA | -12.32 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.26 |
| Operating Margin | -0.27 |
Management Effectiveness
| Return On Assets | -0.22 |
| Return On Equity | -0.51 |
Income Statement
| Revenue | 655.35M |
| Revenue/Share | 5.91 |
| Gross Profit | 488.47M |
| EBITDA | -119.05M |
| Net Income | -136.23M |
| Diluted EPS | -1.22 |
Balance Sheet
| Total Cash | 441.8M |
| Total Cash/Share | 3.87 |
| Total Debt | 234.94M |
| Total Debt/Equity | 0.71 |
| Current Ratio | 2.9 |
| Book Value Per Share | 2.9 |
Price History
| 52-Week Change | -7.16 |
| 52-Week High | 19.25 |
| 52-Week Low | 9.82 |
| Moving Average 50 Days | 14.17 |
| Moving Average 200 Days | 13.05 |
Statistics
| Average Volume | 1.47M |
| Shares Outstanding | 115.82M |
| % Held by Institutions | 88.71 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
